EMDB-41869:
BG505.664 SOSIP in complex with polyclonal antibodies from NHP 8131 (gp120 glycan hole, gp41 glycan hole/fusion peptide and trimer base epitopes)
Method: single particle / : Zhang S, Ward AB

EMDB-41870:
BG505.664 Env SOSIP in complex with polyclonal antibodies from NHP 8131 (gp120-gp120 interface epitope)
Method: single particle / : Zhang S, Ward AB

EMDB-41871:
BG505.664 Env SOSIP in complex with polyclonal antibodies from NHP 8147 (C3/V5, V1/V2/V3 apex, gp41 glycan hole/fusion peptide and trimer base epitopes)
Method: single particle / : Zhang S, Ward AB

EMDB-41872:
BG505.664 Env SOSIP in complex with polyclonal antibodies from NHP 8147 (gp120 glycan hole epitope)
Method: single particle / : Zhang S, Ward AB

EMDB-41972:
GT1.1 SOSIP in complex with wk39 polyclonal antibodies from NHP A12N030 (CD4bs, C3V5 and base epitopes)
Method: single particle / : van Schooten J, Ozorowski G, Ward AB

EMDB-41973:
GT1.1 SOSIP in complex with wk39 polyclonal antibodies from NHP A12N030 (gp41GH/FP and base epitopes)
Method: single particle / : van Schooten J, Ozorowski G, Ward AB

EMDB-41974:
GT1.1 SOSIP in complex with wk39 polyclonal antibodies from NHP DC8G (gp41GH/FP and gp120GH epitopes)
Method: single particle / : van Schooten J, Ozorowski G, Ward AB

EMDB-41975:
GT1.1 SOSIP in complex with wk39 polyclonal antibodies from NHP DC8G (gp120GH and base epitopes)
Method: single particle / : van Schooten J, Ozorowski G, Ward AB

EMDB-41976:
GT1.1 SOSIP in complex with wk39 polyclonal antibodies from NHP DC8G (V1V2V3 and gp120GH epitopes)
Method: single particle / : van Schooten J, Ozorowski G, Ward AB

EMDB-41977:
GT1.1 SOSIP-CC2 in complex with wk80 polyclonal antibodies from NHP 8229 (V1V2V3, C3V5, CD4bs, gp41GH/FP and base epitopes)
Method: single particle / : Sewell LM, Ozorowski G, Ward AB

EMDB-41978:
GT1.1 SOSIP-CC2 in complex with wk80 polyclonal antibodies from NHP 8239 (gp120GH, gp41GH/FP, CD4bs, and base epitopes)
Method: single particle / : Sewell LM, Ozorowski G, Ward AB

EMDB-41498:
HIV-1 BG505 Env SOSIP in complex with bovine Fab Bess4 and non-human primate Fab RM20A3
Method: single particle / : Ozorowski G, Lee WH, Ward AB

EMDB-40981:
BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody FP3
Method: single particle / : Pratap PP, Antansijevic A, Ozorowski G, Ward AB

EMDB-40982:
BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody N289
Method: single particle / : Pratap PP, Antansijevic A, Ozorowski G, Ward AB

EMDB-40822:
BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody IF1
Method: single particle / : Pratap PP, Antansijevic A, Ozorowski G, Ward AB

EMDB-40823:
BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody IF3
Method: single particle / : Pratap PP, Antansijevic A, Ward AB

EMDB-40824:
BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody Base4
Method: single particle / : Pratap PP, Antansijevic A, Ward AB

EMDB-40815:
BG505 SOSIP.664 in complex with wk26 human polyclonal antibodies C3V5, V1V3, N611 and base from participant 017
Method: single particle / : Karlinsey D, Ozorowski G, Ward AB

EMDB-40816:
BG505 SOSIP.664 in complex with wk26 human polyclonal antibodies gp41-N611/FP and base from participant 03
Method: single particle / : Karlinsey D, Ozorowski G, Ward AB

EMDB-40817:
BG505 SOSIP.664 in complex with wk26 human polyclonal antibodies gp41-N611/FP and base from participant 07
Method: single particle / : Karlinsey D, Ozorowski G, Ward AB

EMDB-40818:
BG505 SOSIP.664 in complex with wk26 human polyclonal antibodies gp120-GH and base from participant 09
Method: single particle / : Karlinsey D, Ozorowski G, Ward AB

EMDB-40819:
BG505 SOSIP.664 in complex with wk26 human polyclonal antibodies C3V5, V1V3, gp41-GH/FP and base from participant 11
Method: single particle / : Karlinsey D, Ozorowski G, Ward AB

EMDB-40803:
BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody FP2
Method: single particle / : Pratap PP, Antansijevic A, Ward AB

EMDB-40804:
BG505 Boost2 SOSIP.664 in complex with NHP Polyclonal Antibody FP4
Method: single particle / : Pratap PP, Antansijevic A, Ward AB

EMDB-40805:
BG505 Boost 2 in complex with NHP antibody V1V2
Method: single particle / : Pratap PP, Antansijevic A, Ward AB

EMDB-40806:
BG505 Boost 2 in complex with NHP Polyclonal Antibody N625
Method: single particle / : Pratap PP, Antansijevic A, Ward AB

EMDB-40807:
BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody Base1
Method: single particle / : Pratap PP, Antansijevic A, Ward AB

EMDB-40808:
Boost 2 SOSIP.664 in complex with NHP polyclonal antibody Base2
Method: single particle / : Pratap PP, Antansijevic A, Ward AB

EMDB-40809:
BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody Base3
Method: single particle / : Pratap PP, Antansijevic A, Ward AB

EMDB-40810:
BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody FP1
Method: single particle / : Pratap PP, Antansijevic A, Ozorowski G, Ward AB

EMDB-27346:
nsEM map of hemagglutinin H1 A/Mich/045/15 complexed with polyclonal Fab from individual 182419 at day 0
Method: single particle / : Torrents de la Pena A, Sewall LM, Ward AB

EMDB-27347:
nsEM map of hemagglutinin H1 A/Mich/045/15 complexed with polyclonal Fab samples from individual 182419 at day 0 using Sulfo-SDAD photo-cross-linker
Method: single particle / : Torrents de la Pena A, Sewall LM, Ward AB

EMDB-27348:
nsEM map of hemagglutinin H1 A/Mich/045/15 complexed with polyclonal Fab samples from individual 182419 at day 2
Method: single particle / : Torrents de la Pena A, Sewall LM, Ward AB

EMDB-27349:
nsEM map of hemagglutinin H1 A/Mich/045/15 complexed with polyclonal Fab samples from individual 182419 at day 2 using Sulfo-SDAD photo-cross-linker
Method: single particle / : Torrents de la Pena A, Sewall LM, Ward AB

EMDB-27350:
nsEM map of hemagglutinin H1 A/Mich/045/15 complexed with polyclonal Fab samples from individual 182419 at day 7 using Sulfo-SDAD photo-cross-linker
Method: single particle / : Torrents de la Pena A, Sewall LM, Ward AB

EMDB-27351:
nsEM map of hemagglutinin H1 A/Mich/045/15 complexed with polyclonal Fab samples from individual 182419 at day 28
Method: single particle / : Torrents de la Pena A, Sewall LM, Ward AB

EMDB-27352:
nsEM map of hemagglutinin H1 A/Mich/045/15 complexed with polyclonal Fab samples from individual 182419 at day 28 using Sulfo-SDAD photo-cross-linker
Method: single particle / : Torrents de la Pena A, Sewall LM, Ward AB

EMDB-27353:
nsEM map of hemagglutinin H1 A/Mich/045/15 complexed with polyclonal Fab samples from individual 182419 at day 70
Method: single particle / : Torrents de la Pena A, Sewall LM, Ward AB

EMDB-27354:
nsEM map of hemagglutinin H1 A/Mich/045/15 complexed with polyclonal Fab samples from individual 182419 at day 70 using Sulfo-SDAD photo-cross-linker
Method: single particle / : Torrents de la Pena A, Sewall LM, Ward AB

EMDB-27355:
nsEM map of hemagglutinin H3 A/Sing/INFIMH/16 complexed with polyclonal Fab samples from individual 182419 at day 0
Method: single particle / : Torrents de la Pena A, Sewall LM, Ward AB

EMDB-27356:
nsEM map of hemagglutinin H3 A/Sing/INFIMH/16 complexed with polyclonal Fab samples from individual 182419 at day 0 using Sulfo-SDAD photo-cross-linker
Method: single particle / : Torrents de la Pena A, Sewall LM, Ward AB

EMDB-27357:
nsEM map of hemagglutinin H3 A/Sing/INFIMH/16 complexed with polyclonal Fab samples from individual 182419 at day 2
Method: single particle / : Torrents de la Pena A, Sewall LM, Ward AB

EMDB-27358:
nsEM map of hemagglutinin H3 A/Sing/INFIMH/16 complexed with polyclonal Fab samples from individual 182419 at day 2 using Sulfo-SDAD photo-cross-linker
Method: single particle / : Torrents de la Pena A, Sewall LM, Ward AB

EMDB-27359:
nsEM map of hemagglutinin H1 A/Mich/045/15 complexed with polyclonal Fab samples from individual 182419 at day 7
Method: single particle / : Torrents de la Pena A, Sewall LM, Ward AB

EMDB-27360:
nsEM map of hemagglutinin H3 A/Sing/INFIMH/16 complexed with polyclonal Fab samples from individual 182419 at day 7
Method: single particle / : Torrents de la Pena A, Sewall LM, Ward AB

EMDB-27361:
nsEM map of hemagglutinin H3 A/Sing/INFIMH/16 complexed with polyclonal Fab samples from individual 182419 at day 7 using Sulfo-SDAD photo-cross-linker
Method: single particle / : Torrents de la Pena A, Sewall LM, Ward AB

EMDB-27362:
nsEM map of hemagglutinin H3 A/Sing/INFIMH/16 complexed with polyclonal Fab samples from individual 182419 at day 28
Method: single particle / : Torrents de la Pena A, Sewall LM, Ward AB

EMDB-27363:
nsEM map of hemagglutinin H3 A/Sing/INFIMH/16 complexed with polyclonal Fab samples from individual 182419 at day 28 using Sulfo-SDAD photo-cross-linker
Method: single particle / : Torrents de la Pena A, Sewall LM, Ward AB

EMDB-27364:
nsEM map of hemagglutinin H3 A/Sing/INFIMH/16 complexed with polyclonal Fab samples from individual 182419 at day 70
Method: single particle / : Torrents de la Pena A, Sewall LM, Ward AB

EMDB-27365:
nsEM map of hemagglutinin H3 A/Sing/INFIMH/16 complexed with polyclonal Fab samples from individual 182419 at day 70 using Sulfo-SDAD photo-cross-linker
Method: single particle / : Torrents de la Pena A, Sewall LM, Ward AB